Validity of the use of penbutolol in essential arterial hypertension

Salvatore Corrao, Agnello, Alessandra D'Angelo, Pepe, Scalici, Curiale, Corrao

Risultato della ricerca: Articlepeer review

Abstract

Thirty patients suffering from WHO I-II class slight-moderate essential arterial hypertension were treated with a beta-blocker (Penbutolol) alone and once a day to assess its antihypertensive effectiveness and its affect on heart frequency, lipid metabolism and kidney function. The drug proved highly effective in reducing P.A.S. and P.A.D. values and no negative influence was documented on lipid metabolism, kidney function or heart frequency.
Lingua originaleItalian
pagine (da-a)471-473
Numero di pagine3
RivistaMinerva Medica
Volume81
Stato di pubblicazionePublished - 1990

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2700???

Cita questo